Michael Youssef, M.D.

Neurology
Glioblastoma
Neuro-Oncology

Follow Me

Biography

Michael Youssef, M.D., is an Assistant Professor in the Department of Neurology and the Department of Hematology and Oncology at UT Southwestern Medical Center. He specializes in neuro-oncology.

Dr. Youssef earned his medical degree at the Medical University of South Carolina. He completed a residency in neurology at Baylor College of Medicine and then received advanced training in neuro-oncology through a fellowship at the University of Texas MD Anderson Cancer Center.

Certified by the American Board of Psychiatry and Neurology, he joined the UT Southwestern faculty in 2020.

Dr. Youssef’s clinical and research interests include glioblastoma; primary brain tumors; rare brain tumors, including ependymoma and medulloblastoma; neurologic complications of systemic cancer therapy; brain metastasis; and leptomeningeal disease.

He is a member of the American Academy of Neurology, the American Brain Tumor Association, the Society for Neuro-Oncology, and the American Society for Clinical Oncology.

Education & Training

Fellowship - MD Anderson Cancer Center (2018-2020), Neuro-oncology
Residency - Baylor College of Medicine (2014-2018), Neurology
Medical School - Medical University of South Carolina (2010-2014)

Professional Associations & Affiliations

American Academy of Neurology
American Brain Tumor Association
Society for Neuro-Oncology
American Society for Clinical Oncology

Honors & Awards

American Brain Tumor Association, Summer research grant recipient 2011-2011, Research performed on GBM imaging and response to Temozolomide in patients exposed to O6-BG
Chief Fellow, MD Anderson Cancer Center Department of Neuro-Oncology 2019-2020

Books & Publications

Books
- Metabolic and Nutritional Nervous System Dysfunction in Cancer Patients in Neurological Complications of Systemic Cancer and Antineoplastic Therapy, Second Edition
  Youssef M, Beal T, Mandel J (2020), Newton/Malkin
- Recent Advances for Targeted Therapies in Glioblastoma in Advances in Biology and Treatment of Glioblastoma
  Youssef M., Mandel J., Chowdhary S., Kesari S. (2017), Springer
Publications
- Distance traveled to glioblastoma treatment: A measure of the impact of socioeconomic status on survival.
  Bird CE, Traylor JI, Youssef M, Abdullah KG, Clinical neurology and neurosurgery 2021 Aug 209 106909
- IDH mutation status and the development of venous thromboembolism in astrocytoma patients.
  Mandel JJ, Youssef M, Yust-Katz S, Patel AJ, Jalali A, Li Z, Wu J, Ludmir EB, de Groot JF, Journal of the neurological sciences 2021 Jun 427 117538
- Paraneoplastic syndromes in small cell lung cancer
  Soomro Z, Youssef M, Yust-Katz S, Jalali A, Patel A, Mandel J Journal of Thoracic Disease 2020
- Treatment strategies for glioblastoma in older patients: age is just a number.
  Youssef M, Ludmir EB, Mandel JJ, Patel AJ, Jalali A, Treiber J, Wu J, McAleer MF, de Groot JF, Journal of neuro-oncology 2019 Oct
- Recurrent Papillary Glioneuronal Tumor.
  Goethe EA, Youssef M, Patel AJ, Jalali A, Goodman JC, Mandel JJ, World neurosurgery 2019 Aug 128 127-130
- Effect of health disparities on overall survival of patients with glioblastoma.
  Mandel JJ, Youssef M, Nam J, Patel AJ, Jalali A, Ludmir EB, Liu D, Wu J, Armstrong G, Huse J, Bondy M, de Groot JF, Journal of neuro-oncology 2019 Apr 142 2 365-374
- Treatment Strategies for Glioblastoma in Older Patients: Age is Just a Number.
  Youssef M., Ludmir E., Mandel J., Patel AJ., Jalali A., Treiber J., Wu J., McAleer M., de Groot J. Journal of Neuro-Oncology 2019 145 357-364
- Highlighting the need for reliable clinical trials in glioblastoma.
  Mandel JJ, Youssef M, Ludmir E, Yust-Katz S, Patel AJ, De Groot JF, Expert review of anticancer therapy 2018 10 18 10 1031-1040
- Neurologic complications of immune checkpoint inhibitors in cancer patients.
  Youssef M, Woodman K Neurology 2018
- Recent Advances for Targeted Therapies in Glioblastoma. In: Somasundaram K. (eds) Advances in Biology and Treatment of Glioblastoma.
  Youssef M., Mandel J., Chowdhary S., Kesari S. Current Cancer Research 2017
- Randomized controlled trial of a collaborative care intervention to manage cancer-related symptoms: lessons learned.
  Steel J, Geller DA, Tsung A, Marsh JW, Dew MA, Spring M, Grady J, Likumahuwa S, Dunlavy A, Youssef M, Antoni M, Butterfield LH, Schulz R, Day R, Helgeson V, Kim KH, Gamblin TC, Clinical trials (London, England) 2011 Jun 8 3 298-310
- A prospective study of posttraumatic growth as assessed by self-report and family caregiver in the context of advanced cancer.
  Moore AM, Gamblin TC, Geller DA, Youssef MN, Hoffman KE, Gemmell L, Likumahuwa SM, Bovbjerg DH, Marsland A, Steel JL, Psycho-oncology 2011 May 20 5 479-87
- Health-related quality of life in patients with multiple injuries and traumatic brain injury 10+ years postinjury.
  Steel J, Youssef M, Pfeifer R, Ramirez JM, Probst C, Sellei R, Zelle BA, Sittaro NA, Khalifa F, Pape HC, The Journal of trauma 2010 Sep 69 3 523-30; discussion 530-1
- Physical and psychological functioning of polytrauma patients with traumatic brain injury at 10+ years follow-up.
  Steel JL, Youssef M, Ramirez J, Probst C, Pfeifer R, Zele BA, Sittaro N-A, Khalifa F, Pape HC Journal of Trauma 2009

Research

Cancer Neurology
Glioblastoma
Low-Grade Gliomas
Rare Brain Tumors

Clinical Focus

Glioblastoma
Neuro-Oncology
Primary Brain Tumors
Rare Brain Tumors